Most Reproductive-Aged Women With HIV Infection Are Interested In Using Long-Acting Injectable ART, Survey Finds

Infectious Disease Advisor (8/15, Kuhns) reports, “Most reproductive-aged women with HIV infection are interested in using long-acting injectable antiretroviral therapy (ART) and prefer it over daily oral ART, according to survey results.” The research found “that the majority (63.1%) of patients surveyed reported no concerns regarding the potential impact of long-acting ART on pregnancy.” The findings were published in Clinical Infectious Diseases.